Paradoxical exacerbation of chronic urticaria by H1-antihistamines and montelukast

European Annals of Allergy and Clinical Immunology

Volumn 41, Issue 6, 2009, Pages 187-189

  Tedeschi, A ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Azathioprine; Chronic urticaria; Ciclosporin; H1 antihistamines; Montelukast

Indexed keywords

AZATHIOPRINE; CETIRIZINE; CYCLOSPORIN A; DESLORATADINE; EBASTINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; IMMUNOGLOBULIN E; MONTELUKAST; PREDNISONE; RUPATADINE;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; BLOOD AUTOTRANSFUSION; CASE REPORT; CHRONIC URTICARIA; DISEASE CONTROL; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG TOLERANCE; DRUG WITHDRAWAL; GENERAL CONDITION IMPROVEMENT; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSUPPRESSIVE TREATMENT; MALE; PARADOXICAL DRUG REACTION; PATIENT ASSESSMENT; PRICK TEST; RECURRENT DISEASE; SKIN TEST;

ACETATES; ADULT; AZATHIOPRINE; CHRONIC DISEASE; CYCLOSPORINE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; QUINOLINES; URTICARIA;

EID: 76049094709     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Tedeschi A, Girolomoni G, Asero R; AAITO Committee for Chronic Urticaria and Pruritus Guidelines. AAITO Position paper. Chronic urticaria: diagnostic workup and treatment. Eur Ann Allergy Clin Immunol 2007; 39(7): 225-31.
2. Zuberbier T, Asero R, Bindslev-Jensen C, et al. EAACI/GA(2) LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64(10): 1427-43.
3. Lasthein Andersen S, Bindslev-Jensen C. Treatment of chronic urticaria with high dose antihistamine. Abstract Book XXV Congress of the European Academy of Allergology and Clinical Immunology, Vienna, Austria, 2006; 398 (Abstract).
4. Asero R. Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses. Clin Exp Dermatol 2007; 32(1): 34-8.
5. Demoly P, Messaad D, Benhamed S, Sahla H, Bousquet J. Hypersensitivity to H1-antihistamines. Allergy 2000; 55(7): 679-80.
6. González de Olano D, Roán Roán, de la Hoz Caballer B, Cuevas Agustín M, Hinojosa Macías M. Urticaria induced by antihistamines. J Investig Allergol Clin Immunol 2006; 16(2): 144-6.
7. Inomata N, Tatewaki S, Ikezawa Z. Multipe H1-antihistamine-induced urticaria. J Dermatol 2009; 36(4): 224-7.
8. Weidenger S, Mempel M, Ollert M, et al. Anaphylaxis to mizolastine. J Allergy Clin Imnunol 2004: 114(4): 979-81.
9. Bonanni L, Parmiani S, Sturbini S. Glottis oedema due to loratadine. Allergy 2004; 59(1): 116-7.
10. Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy 2009; 64(9): 1256-68.
11. Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-fiare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006; 117(5): 1113-7.
12. Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999; 140(3): 446-52.
13. Fitzsimons CP, Monczor F, Fernández N, Shayo C, Davio C. Mepyramine, a histamine H1 receptor inverse agonist, binds preferentially to a G protein-coupled form of the receptor and sequesters G protein. J Biol Chem 2004; 279(33): 34431-9.
14. Wedi B, Novacovic V, Koerner M, Kapp A. Chronic urticaria serum induces histamine release, leukotriene production, and basophil CD63 surface expression-inhibitory effects of anti-inflammatory drugs. J Allergy Clin Immunol 2000; 105(3): 552-60.
15. Grattan CE, O'Donnell BF, Francis DM, et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. BrJ Dermatol 2000; 143(2): 365-72.
16. Kessel A, Bamberger E, Toubi E. Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective study. J Am Acad Dermatol 2005; 52(1): 145-8.
17. Shahar E, Bergman R, Guttman-Yassky E, Pollack S. Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids. Int J Dermatol 2006; 45(10): 1224-7.
18. O'Donnell BF, Barr RM, Black AK, et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998; 138(1): 101-6.
19. Pereira C, Tavares B, Carrapatoso I, et al. Low-dose intravenous gammaglobulin in the treatment of severe autoimmune urticaria. Eur Ann Allergy Clin Immunol 2007; 39(7): 237-42.
20. Colombo G, Yacoub MR, Burastero SE, et al. Multiple drug hypersensivity: insight into the underlying mechanism and correlation with autoimmune diseases. Eur Ann Allergy Clin Immunol 2009; 41(2): 50-5.
21. Tedeschi A, Cottini M, Asero R. Simultaneous occurrence of chronic autoimmune urticaria and non-allergic asthma: a common mechanism? Eur Ann Allergy Clin Immunol 2009; 41(2): 56-9.